Investor Presentaiton

31st January 2024 We were pioneers for front-end presence in EM 20 New launches in 9M FY 2024 New Focus Strengthening countries of small presence Pipeline Of healthy product registrations Major Therapeutic segments Cardiac Diabetes Ophthal Pain Derma Gastro Anti Histamine Respiratory = EM Emerging Markets 16 ajanta

View entire presentation